- Home
- CMPX vs MFIN Comparison
CMPX vs MFIN Comparison
Compare CMPX & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- MFIN
- Stock Information
- Founded
- CMPX 2014
- MFIN 1995
- Country
- CMPX United States
- MFIN United States
- Employees
- CMPX N/A
- MFIN N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- MFIN Finance: Consumer Services
- Sector
- CMPX Health Care
- MFIN Finance
- Exchange
- CMPX Nasdaq
- MFIN Nasdaq
- Market Cap
- CMPX 229.5M
- MFIN 207.3M
- IPO Year
- CMPX N/A
- MFIN 1996
- Fundamental
- Price
- CMPX $1.82
- MFIN $9.17
- Analyst Decision
- CMPX Strong Buy
- MFIN
- Analyst Count
- CMPX 8
- MFIN 0
- Target Price
- CMPX $13.13
- MFIN N/A
- AVG Volume (30 Days)
- CMPX 762.7K
- MFIN 43.3K
- Earning Date
- CMPX 05-08-2025
- MFIN 04-30-2025
- Dividend Yield
- CMPX N/A
- MFIN 4.80%
- EPS Growth
- CMPX N/A
- MFIN N/A
- EPS
- CMPX N/A
- MFIN 1.60
- Revenue
- CMPX $850,000.00
- MFIN $316,751,000.00
- Revenue This Year
- CMPX $47.65
- MFIN N/A
- Revenue Next Year
- CMPX $2,622.79
- MFIN $6.21
- P/E Ratio
- CMPX N/A
- MFIN $5.72
- Revenue Growth
- CMPX N/A
- MFIN 13.93
- 52 Week Low
- CMPX $0.77
- MFIN $6.48
- 52 Week High
- CMPX $4.08
- MFIN $10.50
- Technical
- Relative Strength Index (RSI)
- CMPX 46.49
- MFIN 60.44
- Support Level
- CMPX $1.79
- MFIN $9.00
- Resistance Level
- CMPX $1.95
- MFIN $9.34
- Average True Range (ATR)
- CMPX 0.14
- MFIN 0.28
- MACD
- CMPX 0.01
- MFIN 0.04
- Stochastic Oscillator
- CMPX 29.52
- MFIN 79.76
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.